Data Characteristics in this Domain
Pharmacoeconomic data primarily originates from drug clinical trial reports, real-world evidence (RWE) databases, health insurance reimbursement policy documents, drug pricing documents, and reports published by various Health Technology Assessment (HTA) agencies. Data update frequencies vary. Clinical trial reports are typically released after trial completion. RWE databases may update quarterly or annually. Policy documents change according to government publication cycles. Document structures are highly standardized. For example, clinical trial reports follow ICH GCP guidelines, including detailed trial protocols, statistical analysis plans, results, and discussions. Fields include drug costs (in USD, EUR, or RMB), efficacy (e.g., QALY, LYG, in years, months, or percentages), adverse event rates, patient demographic characteristics, and country- or region-specific medical service pricing codes (e.g., ICD-10, DRG).
Constraints Imposed by these Characteristics on "Citing Sources and Traceability"
The standardized nature of pharmacoeconomic data requires source citations to be precise, down to specific sections, tables, or appendices, to ensure data verifiability. Source diversity means the knowledge base must integrate data from various formats and sources, such as PDFs, Excel files, and database records, and accurately identify their original provenance. Varying update frequencies challenge the knowledge base's real-time capabilities; outdated data can lead to skewed evaluation results. Therefore, data versions and update dates must be clearly identified. The specificity of fields and units requires distinguishing different cost types (direct costs, indirect costs) and efficacy metrics with their respective units during citation to avoid confusion. Furthermore, the timeliness of policy documents requires the citation system to track policy changes, ensuring that cited regulations are currently valid. This is crucial for the reliability of pre-screening results.
Configuration Settings
| Configuration Item | Recommended Value | Rationale for Recommendation |
|---|---|---|
maxContext | 3000 characters | Pharmacoeconomic documents often contain extensive quantitative data and detailed arguments, requiring a longer context for complete semantic understanding. |
Recall count (Recall Count) | 8 items | Ensures coverage of relevant data points from different sources and time dimensions, improving the comprehensiveness of pre-screening results. |
Similarity threshold (Similarity Threshold) | 0.75 | Pharmacoeconomic concepts are rigorous; increasing the threshold reduces recall of semantically similar but irrelevant content, focusing on core information. |
Chunk size (Segment Length) | 500 characters | Balances the completeness of individual data points with retrieval efficiency, avoiding excessive splitting that leads to context loss. |
Rerank result count (Reranked Return Count) | 3 items | Prioritizes the most relevant and information-dense citations, improving user efficiency in obtaining key information. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Processing large clinical trial reports or complex policy documents can be time-consuming; increasing the timeout reduces parsing failures. |
Three Common Mistakes
- Citation results include many irrelevant policy documents: This might be due to a
Similarity threshold(Similarity Threshold) set too low, leading to the recall of documents with non-core keywords. - Cost data and efficacy data in clinical trial reports cannot be matched: This might be because the knowledge base's segmentation strategy did not consider the structural relationships within tables or charts, leading to context fragmentation.
- Cited data units are inconsistent or fields are confusing in the output: This might be because the knowledge base did not identify and standardize specific fields (e.g., currency units, time units) within documents.
How to Confirm Correct Configuration
- For typical pharmacoeconomic pre-screening questions, check if the output's cited sources accurately point to specific page numbers or sections in the original documents.
- Verify that the cited data (e.g., drug costs, QALY values) completely matches the data in the original documents and that units are correct.
- Simulate a policy update scenario to verify that the system prioritizes citing the latest version of policy documents and identifies the invalid status of older policies.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.